Seeking Alpha

St. Jude Medical (STJ +0.2%) says data from its catheter study, presented today at the annual...

St. Jude Medical (STJ +0.2%) says data from its catheter study, presented today at the annual scientific meeting of the American Heart Association, showed that it’s EnligHTN renal denervation system provided a significant reduction in office and ambulatory blood pressure measurements at six months. In addition, those treated with the system began experiencing a reduction in blood pressure reduction after just 30 days.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)